|
ELMO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.700150E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.135190E-01 |
| Normal-vs-Stage2 |
9.131200E-01 |
| Normal-vs-Stage3 |
9.092000E-01 |
| Normal-vs-Stage4 |
2.664600E-03 |
| Stage1-vs-Stage2 |
5.391400E-01 |
| Stage1-vs-Stage3 |
4.603400E-01 |
| Stage1-vs-Stage4 |
2.690800E-01 |
| Stage2-vs-Stage3 |
9.869800E-01 |
| Stage2-vs-Stage4 |
1.309820E-01 |
| Stage3-vs-Stage4 |
1.547820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.147200E-01 |
| Normal-vs-AfricanAmerican |
2.039400E-01 |
| Normal-vs-Asian |
5.629200E-01 |
| Caucasian-vs-AfricanAmerican |
7.246000E-01 |
| Caucasian-vs-Asian |
8.965600E-01 |
| AfricanAmerican-vs-Asian |
9.932600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.197700E-02 |
| Normal-vs-Female |
8.700600E-01 |
| Male-vs-Female |
1.584220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.941900E-02 |
| Normal-vs-Extreme_Weight |
3.487700E-02 |
| Normal-vs-Obese |
7.524200E-01 |
| Normal-vs-Extreme_Obese |
1.469150E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.896000E-01 |
| Normal_Weight-vs-Obese |
1.731970E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.595800E-01 |
| Extreme_Weight-vs-Obese |
1.740420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.249000E-01 |
| Obese-vs-Extreme_Obese |
2.639000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.230800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.844200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.276300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.402900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.135800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.015700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.103750E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.357630E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.258490E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.168300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.840800E-01 |
| Normal-VS-Type2 PRCC |
2.772600E-04 |
| Normal-VS-KIRP CIMP |
2.399800E-01 |
| Normal-VS-Unclassified PRCC |
1.347000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.240200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.244200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.602500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.088000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.845700E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.285900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.015000E-01 |
| Normal-vs-N1 |
3.547400E-01 |
| Normal-vs-N2 |
3.833800E-01 |
| N0-vs-N1 |
6.139200E-01 |
| N0-vs-N2 |
7.249400E-01 |
| N1-vs-N2 |
4.460200E-01 |
|
|
